Blood Draw Study for Liver Transplant Patients

Liver Transplant Recipients Clinical Trial

Official title:

Immunomonitoring of Transplant Patients

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT01525797
• Other study ID #: 002-197
• Status: Active, not recruiting
• Phase: N/A
• First received: May 11, 2011
• Last updated: March 13, 2015
• Start date: October 2002
• Est. completion date: November 2015

Study information

• Verified date: March 2015
• Source: Baylor Research Institute
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review BoardUnited States: Food and Drug Administration
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to see what a lab test will show and if there is a way to predict which patients will be more likely to have rejection after receiving a liver transplant.

Description:

The purpose of this study is simply to see what the new oligonucleotide microarrays will show when comparing the the different patient groups. The results of this study will be one of the first steps In exploring the potential use of this new test.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 200
• Est. completion date: November 2015
• Est. primary completion date: November 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 17 Years to 65 Years

Eligibility

Inclusion Criteria:

• Received a liver Transplant

Exclusion Criteria:

• Received Multiple Organ Transplant

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• Liver Transplant Recipients

Locations

Country	Name	City	State
United States	Baylor University Medical Center	Dallas	Texas

Sponsors (1)

Lead Sponsor	Collaborator
Baylor Research Institute

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Identify signatures predictive of graft rejection or tolerance.	Analyze the pattern of gene expression in patients undergoing solid organ transplantation	2 years	No